Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060925 · ClinicalTrials.gov registry record
Imaging Biomarkers for Myofascial Pain
A clinical trial, sponsored by George Mason University.
- Completed
- Registry status
- 96
- Enrollment target
NCT06060925 is a clinical trial that has completed, run by George Mason University. The registered enrollment target is 96 participants.
The verdict
NCT06060925 has completed, sponsored by George Mason University.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
Myofascial pain syndrome (MPS) is highly prevalent in the community. It is primarily diagnosed using patient self reports and physical examination, which lack reliability, sensitivity and specificity and does not provide insights into the abnormal biological and physiological processes in soft tissues. While a number of treatment methods are available to patients, there are currently no criteria to determine which treatments might be best for each patient's unique myofascial pain phenotype. To improve evidence-based management of myofascial pain, there is a critical need to develop quantitative measures that advance the understanding of the physiological processes in the underlying the soft tissues across the clinical continuum of MPS. The objective of this project is to develop a quantitative biomarker informed by the current understanding of underlying tissue-level mechanisms at the level of the "myofascial unit" (muscle, nerve, fascia, vasculature, lymphatics) that are likely to be involved in MPS.
Interventions
- DIAGNOSTIC_TEST Ultrasound imaging
- DIAGNOSTIC_TEST Electromyography
- DIAGNOSTIC_TEST Physical examination
- DIAGNOSTIC_TEST Bioimpedance spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06060925
The ClinicalTrials.gov registry entry for NCT06060925 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Mason University, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ultrasound imaging is the first listed.
NCT06060925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06060925 about?
NCT06060925 is a clinical study titled "Imaging Biomarkers for Myofascial Pain". Myofascial pain syndrome (MPS) is highly prevalent in the community. It is primarily diagnosed using patient self reports and physical examination, which lack reliability, sensitivity and specificity and does not provide insights into the abnormal biological and physiological processes in soft tissu...
What is the current status of trial NCT06060925?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2023-01-01. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT06060925?
The interventions under investigation include: Ultrasound imaging (DIAGNOSTIC_TEST), Electromyography (DIAGNOSTIC_TEST), Physical examination (DIAGNOSTIC_TEST), Bioimpedance spectroscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06060925?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.